#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Drug eruption Heart disease congenital Scedosporium infection Pemphigus Bladder cancer Alport's syndrome Gestational trophoblastic tumour Hyperchylomicronaemia Anaplastic thyroid cancer Anal cancer Lymphatic malformation Optic glioma Antithrombin III deficiency Thalassaemia Follicular lymphoma More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Treatment Splenic marginal zone lymphoma – Life with Disease Alport’s syndrome – Basic Information Pemphigoid – Life with Disease Krabbe’s disease – Treatment Synovial sarcoma – Trials in Disease Hereditary neuropathic amyloidosis – Life with Disease Prolymphocytic leukaemia – Treatment Metachromatic leukodystrophy Primary hyperoxaluria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-15Bo-116 Ecoo6A L-ARGININE Bgb-15025 Citrate Festuca Rubra Pollen LY3372993 GS-248 Iomeprol Cyclophosphamide [14C] DC-806 Pegipanermin DNL593 AUR200 Phenylbutyrate Ciltacabtagene Autoleucel LIPASE ACT-1004-1239 Escitalopram Oxalate Belantamab Mafodotin Bi 3720931 More therapies…

    Learn about Your Condition

    Papilloma viral infection Cortisol abnormal Primary amyloidosis Childhood asthma Respiratory failure Clostridium difficile colitis Colorectal cancer metastatic Limb reduction defect Rosai-Dorfman syndrome Cervix carcinoma stage IV Skin candida Head and neck cancer stage III Bacterial prostatitis Bronchiectasis Aortic valve disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute kidney injury

  • Effect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • MAGNESIUM ACETATE TETRAHYDRATE
    • Magnesium Chloride Hexahydrate
    • MALIC ACID
    Germany

  • A study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    • Acute kidney injury
    Investigated Drugs:
    • R2R01
    • Sodium Chloride
    Germany Italy

  • A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis

    Recruiting

    2 1
    Investigated Diseases:
    • Acute kidney injury
    Belgium Czechia Denmark France Germany Greece +3

  • Study of hydrocortisone and fludrocortisone in patients with intermediate/high-risk scheduled cardiac surgery to prevent complications

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cellulose, Microcrystalline
    • Fludrocortisone
    • Hydrocortisone
    France

  • Study on Reducing Acute Kidney Injury After Heart Surgery Using Angiotensin II or Noradrenaline for Patients with Low Blood Pressure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • ANGIOTENSIN II
    • Noradrenaline Tartrate
    Germany

  • Study on the Effect of Human Serum Albumin in Critically Ill Patients with Septic Shock at High Risk of Acute Kidney Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    • Acute kidney injury
    Investigated Drugs:
    • Human Serum Albumin
    Spain
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!